MCK Quote, Financials, Valuation and Earnings

Cardinal Health has a net margin of 0.92% compared to McKesson's net margin of 0.72%. McKesson's return on equity of -- beat Cardinal Health's return on equity of --.

McKesson has a consensus price target of $672.51, signalling upside risk potential of 1.03%. On the other hand Cardinal Health has an analysts' consensus of $141.34 which suggests that it could grow by 3.43%. Given that Cardinal Health has higher upside potential than McKesson, analysts believe Cardinal Health is more attractive than McKesson.

McKesson has a beta of 0.516, which suggesting that the stock is 48.439% less volatile than S&P 500. In comparison Cardinal Health has a beta of 0.659, suggesting its less volatile than the S&P 500 by 34.133%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.41%. Cardinal Health offers a yield of 1.48% to investors and pays a quarterly dividend of $0.51 per share. McKesson pays 10.46% of its earnings as a dividend. Cardinal Health pays out 58.57% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $95.3B, which are larger than Cardinal Health quarterly revenues of $55.3B. McKesson's net income of $879M is higher than Cardinal Health's net income of $400M. Notably, McKesson's price-to-earnings ratio is 30.48x while Cardinal Health's PE ratio is 25.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.25x versus 0.15x for Cardinal Health. Usually stocks with elevated PS ratios are considered overvalued.

Cencora has a net margin of 0.92% compared to McKesson's net margin of 0.6%. McKesson's return on equity of -- beat Cencora's return on equity of 155.22%.

McKesson has a consensus price target of $672.51, signalling upside risk potential of 1.03%. On the other hand Cencora has an analysts' consensus of $281.09 which suggests that it could grow by 2.6%. Given that Cencora has higher upside potential than McKesson, analysts believe Cencora is more attractive than McKesson.

McKesson has a beta of 0.516, which suggesting that the stock is 48.439% less volatile than S&P 500. In comparison Cencora has a beta of 0.507, suggesting its less volatile than the S&P 500 by 49.306%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.41%. Cencora offers a yield of 0.77% to investors and pays a quarterly dividend of $0.55 per share. McKesson pays 10.46% of its earnings as a dividend. Cencora pays out 27.58% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $95.3B, which are larger than Cencora quarterly revenues of $81.5B. McKesson's net income of $879M is higher than Cencora's net income of $488.6M. Notably, McKesson's price-to-earnings ratio is 30.48x while Cencora's PE ratio is 38.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.25x versus 0.18x for Cencora. Usually stocks with elevated PS ratios are considered overvalued.

Henry Schein has a net margin of 0.92% compared to McKesson's net margin of 2.95%. McKesson's return on equity of -- beat Henry Schein's return on equity of 7.8%.

McKesson has a consensus price target of $672.51, signalling upside risk potential of 1.03%. On the other hand Henry Schein has an analysts' consensus of $79.38 which suggests that it could grow by 14.39%. Given that Henry Schein has higher upside potential than McKesson, analysts believe Henry Schein is more attractive than McKesson.

McKesson has a beta of 0.516, which suggesting that the stock is 48.439% less volatile than S&P 500. In comparison Henry Schein has a beta of 0.900, suggesting its less volatile than the S&P 500 by 10.008%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.41%. Henry Schein offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.46% of its earnings as a dividend. Henry Schein pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $95.3B, which are larger than Henry Schein quarterly revenues of $3.2B. McKesson's net income of $879M is higher than Henry Schein's net income of $94M. Notably, McKesson's price-to-earnings ratio is 30.48x while Henry Schein's PE ratio is 22.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.25x versus 0.70x for Henry Schein. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple has a net margin of 0.92% compared to McKesson's net margin of --. McKesson's return on equity of -- beat Pineapple's return on equity of --.

McKesson has a consensus price target of $672.51, signalling upside risk potential of 1.03%. On the other hand Pineapple has an analysts' consensus of -- which suggests that it could fall by --. Given that McKesson has higher upside potential than Pineapple, analysts believe McKesson is more attractive than Pineapple.

McKesson has a beta of 0.516, which suggesting that the stock is 48.439% less volatile than S&P 500. In comparison Pineapple has a beta of 30.176, suggesting its more volatile than the S&P 500 by 2917.584%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.41%. Pineapple offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.46% of its earnings as a dividend. Pineapple pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $95.3B, which are larger than Pineapple quarterly revenues of --. McKesson's net income of $879M is higher than Pineapple's net income of --. Notably, McKesson's price-to-earnings ratio is 30.48x while Pineapple's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.25x versus 34.40x for Pineapple. Usually stocks with elevated PS ratios are considered overvalued.